<i>In vivo</i> delivery of PBAE/ZIF-8 enhances the sensitivity of colorectal cancer to doxorubicin through sh-LncRNA ASB16-AS1
Qing Yang(Guangzhou University of Chinese Medicine), Rongzhou Li(Wenzhou Medical University), Xiaoqiu Wu(Chinese Academy of Sciences), Tingting Ji(Wenzhou Medical University), Xiaosheng Jin(Tongde Hospital of Zhejiang Province), Haiying Lin(Wenzhou Medical University), Yuansen Zhang(Wenzhou Medical University)
Cited by 5
Related Papers
Sumoylation Promotes the Stability of the DNA Sensor cGAS and the Adaptor STING to Regulate the Kinetics of Response to DNA Virus
|Immunity|2016|378
Safety, Activity, and Biomarkers of SHR-1210, an Anti-PD-1 Antibody, for Patients with Advanced Esophageal Carcinoma
|Clinical Cancer Research|2018|218
Safety, anti-tumour activity, and pharmacokinetics of fixed-dose SHR-1210, an anti-PD-1 antibody in advanced solid tumours: a dose-escalation, phase 1 study
|British Journal of Cancer|2018|156
Targeting cellular heterogeneity with CXCR2 blockade for the treatment of therapy-resistant prostate cancer
|Science Translational Medicine|2019|138